Li SJ - Search Results

1

[Expression of translationally controlled tumor protein in human breast cancer and its clinical significance].

Li SJ, Jia HY, Wu D, Fan ZM. Li SJ, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Sep;31(9):1560-3. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 21945766 Chinese.

2

Ca2+-binding protein S100A11: a novel diagnostic marker for breast carcinoma.

Liu XG, Wang XP, Li WF, Yang S, Zhou X, Li SJ, Li XJ, Hao DY, Fan ZM. Liu XG, et al. Among authors: li wf, li xj, li sj. Oncol Rep. 2010 May;23(5):1301-8. doi: 10.3892/or_00000764. Oncol Rep. 2010. PMID: 20372844

3

Clinical features and prognosis of a unilateral fibroadenoma of the breast in a 16-month-old female.

Shi A, Li S, Xu N, Nie G, Li X, Zhang T, Fan Z. Shi A, et al. Jpn J Clin Oncol. 2011 Feb;41(2):260-4. doi: 10.1093/jjco/hyq181. Epub 2010 Oct 11. Jpn J Clin Oncol. 2011. PMID: 20937600

4

Subcutaneous Nipple-Sparing Mastectomy and Immediate Breast Reconstruction.

Shi A, Wu D, Li X, Zhang S, Li S, Xu H, Xie H, Fan Z. Shi A, et al. Breast Care (Basel). 2012 Apr;7(2):131-136. doi: 10.1159/000337640. Epub 2012 Apr 25. Breast Care (Basel). 2012. PMID: 22740800 Free PMC article.

5

COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.

Du Y, Shi A, Han B, Li S, Wu D, Jia H, Zheng C, Ren L, Fan Z. Du Y, et al. Int J Oncol. 2014 Apr;44(4):1385-93. doi: 10.3892/ijo.2014.2299. Epub 2014 Feb 12. Int J Oncol. 2014. PMID: 24535190

6

Low-dose irradiation promotes proliferation of the human breast cancer MDA-MB-231 cells through accumulation of mutant P53.

Li SJ, Liang XY, Li HJ, Li W, Zhou L, Chen HQ, Ye SG, Yu DH, Cui JW. Li SJ, et al. Among authors: li w, li hj. Int J Oncol. 2017 Jan;50(1):290-296. doi: 10.3892/ijo.2016.3795. Epub 2016 Dec 6. Int J Oncol. 2017. PMID: 27959407

7

Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel.

Jin Y, Hu W, Liu T, Rana U, Aguilera-Barrantes I, Kong A, Kumar SN, Wang B, Gao P, Wang X, Duan Y, Shi A, Song D, Yang M, Li S, Han B, Zhao G, Fan Z, Miao QR. Jin Y, et al. Cancer Lett. 2018 Apr 10;419:233-244. doi: 10.1016/j.canlet.2018.01.054. Epub 2018 Feb 2. Cancer Lett. 2018. PMID: 29373839 Free PMC article.

8

Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells.

Gao P, Wang X, Jin Y, Hu W, Duan Y, Shi A, Du Y, Song D, Yang M, Li S, Han B, Zhao G, Zhang H, Fan Z, Miao QR. Gao P, et al. Breast Cancer Res. 2018 Sep 12;20(1):112. doi: 10.1186/s13058-018-1028-5. Breast Cancer Res. 2018. PMID: 30208932 Free PMC article.

9

Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway.

Li Z, Yu D, Li H, Lv Y, Li S. Li Z, et al. Int J Oncol. 2019 Mar;54(3):1033-1042. doi: 10.3892/ijo.2019.4679. Epub 2019 Jan 8. Int J Oncol. 2019. PMID: 30628639

10

RETRACTED: Znhit1 inhibits breast cancer by up-regulating PTEN to deactivate the PI3K/Akt/mTOR pathway.

Cui C, Li S, Wu D. Cui C, et al. Life Sci. 2019 May 1;224:204-211. doi: 10.1016/j.lfs.2019.03.067. Epub 2019 Mar 27. Life Sci. 2019. Retraction in: Life Sci. 2022 Sep 15;305:120746. doi: 10.1016/j.lfs.2022.120746 PMID: 30928405 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,903 results

Search Page

Filters